ReNAgade Therapeutics

About:

ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.

Website: https://renagadetx.com

Twitter/X: ReNAgadeTx

Top Investors: MPM Capital, F2 Ventures

Description:

ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease. RNA delivery systems with a comprehensive RNA platform that allows for an all-RNA system for coding, editing, and gene insertion to produce new medications.

Total Funding Amount:

$300M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)renagadetx.com

Founders:

Brian Goodman

Number of Employees:

101-250

Last Funding Date:

2023-05-23

IPO Status:

Private

© 2025 bioDAO.ai